Ticker Details
Protagonist Therapeutics, Inc. Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.
IPO Date:	August 11, 2016
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.64B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.62 | 2.81%
Avg Daily Range (30 D):	$2.32 | 2.39%
Avg Daily Range (90 D):	$1.76 | 1.95%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	.63M
Avg Daily Volume (90 D):	.59M

Trade Size
Avg Trade Size (Sh.):	71
Avg Trade Size (Sh.) (30 D):	44
Avg Trade Size (Sh.) (90 D):	46

Institutional Trades
Total Institutional Trades:	3,259
Avg Institutional Trade:	$3.34M
Avg Institutional Trade (30 D):	$11.41M
Avg Institutional Trade (90 D):	$8.14M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.07M
Avg Closing Trade (30 D):	$20.41M
Avg Closing Trade (90 D):	$16.11M
Avg Closing Volume:	149.5K

News

Apr 2, 2026 @ 10:14 AM This Healthcare Stock Barely Flinches During Marke... Source: James Halley

Mar 19, 2026 @ 12:25 PM Johnson & Johnson-Protagonist Therapeutics Partner... Source: Vandana Singh

Feb 25, 2026 @ 8:28 PM Protagonist Stock Up 120%, but One Fund Just Revea... Source: Jonathan Ponciano

Oct 23, 2025 @ 6:25 PM Moody Aldrich Dumps Entire Stake in Chart Industri... Source: Adam Palasciano

Oct 21, 2025 @ 9:03 PM Moody Aldrich Liquidates Entire Stake in PLMR Wort... Source: Adam Palasciano

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.05	$-.7	$-2.05
Diluted EPS	$-2.05	$-.7	$-2.05
Revenue	$46.02M	$7.44M	$46.02M
Gross Profit
Net Income / Loss	$-130.15M	$-44.38M	$-130.15M
Operating Income / Loss	$-158.13M	$-50.36M	$-158.13M
Cost of Revenue
Net Cash Flow	$31.2M	$14.68M	$31.2M
PE Ratio